Zoetis Inc. (ZTS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 158.42 |
| Open | 158.42 |
| Bid | 160.21 x 1100 |
| Ask | 162.69 x 1100 |
| Day's range | 158.42 - 165.04 |
| 52-week range | 144.80 - 201.92 |
| Volume | |
| Avg. volume | 3,547,900 |
| Market cap | 72.974B |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | 31.56 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.73 (1.08%) |
| Ex-dividend date | 18 Apr 2024 |
| 1y target est | N/A |
- Zacks
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Insider Monkey
10 Most Promising Stocks to Buy Before They Take Off
In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue by 27% in Q1, Provides Weak Outlook for FY ’24 The market […]
- Zacks
Unveiling Zoetis (ZTS) Q1 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.